NR1H4 and steatosis: Hepatic immune microenvironment abnormalities in MASLD include: Hepatic TRM FXR expression correlated with steatosis severity, implying FXR dysregulation drives TRM’s “anti-inflammatory-to-pro-inflammatory” shift.